LinkedIn: 🌟 Women in Science: Cytiva’s @Beate Mueller, an eternal technology optimist, shares her inspiring journey in the biotech world. From molecular biology to leading teams delivering advanced therapies, she highlights the power of diversity in solving today’s scientific challenges. 💡👩🔬 #WomenInSTEM #BiotechInnovation Cytiva https://lnkd.in/grZcuMHq
Outsourcing-Pharma’s Post
More Relevant Posts
-
The nutraceutical industry stands at a pivotal crossroads, where the inclusion and empowerment of women in STEM fields have never been more critical. In the insightful article "Women in STEM: Past, Present, and Future of the Nutraceutical Industry," Karin Linnewiel Hermoni, Co-Chair of WIN’s Science Committee, highlights the challenges and triumphs women face in this dynamic field. At Women In Nutraceuticals (WIN), we recognize that empowering women in STEM is not just a goal—it’s a necessity. The nutraceutical industry is evolving, and with it, the opportunities for women to lead, innovate, and make a lasting impact on global health and wellness. Read Karin's article here: https://lnkd.in/gxzuRxPv Thank you Women In Nutraceuticals World for continuing to highlight these critically important topics. Julia Wiebe, PhD Petra Erlandson Suzanne Shelton Rebecca Wright Yalda Shokooh Leena Pradhan-Nabzdyk, PhD, MBA Karin Linnewiel Hermoni Karen Hecht, Ph.D. Angela Mastaloudis, Ph.D. Susan Hewlings Denise Cibu Dr. Premalatha Balachandran, Ph. D. MBA, Dr. Susan Kleiner Yasmeen Nkrumah-Elie, PhD Mariko Hill Sudipta Veeramachaneni #WomenInNutraceuticals #WINtogether #GenderParity #genderequity #WINscience #WomenInSTEM #Nutraceuticals #Mentorship #Diversity #Innovation #Leadership #Empowerment
Women in STEM: Past, Present and Future of the Nutraceutical Industry
nutraceuticalsworld.com
To view or add a comment, sign in
-
August is National Inventors Month! Today, we are honoring three remarkable women inventors whose groundbreaking work has made a lasting impact: 🔧 Bessie Blount Griffin: Inventor of the feeding tube, Bessie transformed healthcare by providing a tool that restored independence to individuals with disabilities. 🔬 Ann Tsukamoto: A pioneer in stem cell research, Ann's co-patented process for isolating stem cells has been crucial in advancing medical treatments and research. 💻 Evelyn Berezin: Creator of the first computer-driven word processor, Evelyn's innovation changed the way we work and communicate, opening new possibilities in technology and business. For women business owners, these stories serve as powerful examples of innovation and resilience. Let’s recognize and celebrate the contributions of these incredible women, and be inspired to continue breaking new ground. #NationalInventorsMonth #WomenInBusiness #Innovation #WISEWBC #Trailblazers
To view or add a comment, sign in
-
**Anne Wojcicki: A Trailblazer in Life Science and Technology** Anne Wojcicki is a visionary entrepreneur, scientist, and investor who has made significant contributions to the fields of life science and technology. Her journey is an inspiring story of determination, innovation, and the power of collaboration. **Early Life and Education:** Born in Palo Alto, California, Anne earned her bachelor's degree in biology from Yale University and later pursued a doctorate in molecular biology and genetics from the University of California, San Diego. Her passion for science and research led her to pursue a career in biotechnology. **Co-founding 23andMe:** In 2006, Anne co-founded 23andMe, a personal genomics and biotechnology company that revolutionized the field of personalized medicine. 23andMe offers DNA testing services that empower individuals to understand their genetic predispositions, health risks, and ancestry. **Empowering Individuals through Genetics:** Anne's vision for 23andMe was to make genetic information accessible and affordable to everyone. She believed that by empowering individuals with knowledge of their own genetics, they could make informed healthcare decisions and improve their overall well-being. **Building Partnerships and Collaborations:** To drive innovation and advance the field of genomics, Anne has forged partnerships with leading research institutions, pharmaceutical companies, and policymakers. These collaborations have enabled 23andMe to contribute to groundbreaking discoveries and develop personalized therapies. **Commitment to Diversity and Inclusion:** Anne is a vocal advocate for diversity and inclusion in science and technology. She has established programs and initiatives to support underrepresented groups and create a more equitable and inclusive environment. **Impact and Recognition:** Anne's contributions have been recognized with numerous awards and accolades. She is a member of the National Academy of Sciences, a recipient of the Horatio Alger Award, and was named one of Time magazine's 100 Most Influential People. **Inspiring Future Generations:** Anne's passion for science and her dedication to making a positive impact in the world serve as an inspiration for countless young scientists and entrepreneurs. She is a role model for women in STEM and a testament to the power of collaboration and innovation in driving social change. Anne Wojcicki is a role model for women in science and technology. Who are some other inspiring women in STEM whose stories should be highlighted? Share their names and achievements below! #womeninstem #lifescience #genomics #personalizedmedicine #diversityintech #innovation
To view or add a comment, sign in
-
The rise of women-led biotech companies is a testament to the power of diversity in driving innovation and progress. This is my blog on the contribution of women to biotechnology. BioLabShare - creating opportunity, opening doors, diversifying biotechnology https://lnkd.in/engNzCJY
Title: Driving Innovation: Women-Led Biotech Companies Pioneering STEM Diversity
usstemdiversity.blogspot.com
To view or add a comment, sign in
-
What does it take to be a young scientist making waves across continents? In the fourth episode of “In Conversation With,” I sit down with Rakshi Anuja Dinesh, a young scientist breaking barriers and redefining what it means to lead in life sciences. From being a gold medalist with an exceptional GPA of 9.85/10 at Sathyabama Institute to pursuing her MSc in Biotechnology at the University of Queensland, Rakshi has already left her mark. Her work spans intellectual property analysis for flavivirus vaccines to pioneering nanomaterials for biomedical applications—all while publishing high-impact research on AI in healthcare and drug delivery systems. But Rakshi’s story goes beyond achievements. It’s about resilience, innovation, and challenging norms—qualities that inspire a new generation of women to step confidently into STEM fields. This conversation is for every young woman, every curious mind, and every advocate of innovation who believes that science has no boundaries. Join us as we uncover Rakshi’s journey, insights, and her bold take on shaping the future of biotechnology. 📍 Don’t miss this episode—because stories like hers deserve to be heard. When: December 21, 11 A.M. Where: HerKey https://lnkd.in/gsFQn3Zc Drop a 🔬 in the comments if you're tuning in! #LeadershipDevelopment #WomenInSTEM #Innovation #CorporateTraining #FutureLeaders #ProfessionalDevelopment #LearningAndDevelopment #Inspiration #CareerGrowth #SkillBuilding
To view or add a comment, sign in
-
You can read the interview with Rana Sanyal 🌹
Join us in celebrating #WomenInSTEM 👩🔬 We are thrilled to spotlight Professor Rana Sanyal, Türkiye’s first #MarieSkłodowskaCurieActions fellow and the 2024 #WiPrizeEU winner in the Women Innovators category! 🏆 At RS Research, Prof. Sanyal pioneers game-changing technologies, leading the development of smart #nanomedicines for targeted #chemotherapy. Her work not only pushes the boundaries of biotechnological research but also inspires countless young researchers, especially women, to pursue careers in STEM. In our interview, Prof. Sanyal discusses how #MSCA funding has empowered her team to innovate and collaborate across borders, bridging #academia and #industry to accelerate research into tangible solutions. 🔗 Read the full interview: europa.eu/!rHrGgr
To view or add a comment, sign in
-
Great article highlighting women leaders in life sciences for 2024, celebrating their contributions to innovation, business growth, and healthcare impact. It showcases diverse achievements across pharmaceuticals, biotech, and related fields, emphasizing leadership, ground-breaking research, and advancements in medicine and patient care. For the full details, you can explore the article: https://lnkd.in/ey6qSGUF #womeninstem #divesity #DEI #femaleleaders
2024's Fiercest Women in Life Sciences
fiercepharma.com
To view or add a comment, sign in
-
Have you ever read the book Silent Spring? It details a world where chemicals ravage the earth - and there is even another book called Grapes of Wrath that details how chemicals destroy our relationship with Mother Nature herself. I have come to understand that male biology is sensitive. Men are disappearing. I have been reading papers about how microplastics mimic estrogen at the molecular level - we see a rise in gender queerness with more men having worse health outcomes at the hormonal level (also interesting to note that more people are using steroids than ever in human history). I sorta wonder - not from a manosphere perspective or a feminist one - but from a biological perspective - is male biology fragile? For every $1 invested in biology only something like less than 2 cents is invested in female biology research. We know less about female biology than any other subject on earth. So I wonder - what will future populations look like in a world full of estrogenic pollutants? Lots of men with little to no women? Lots of women with little to no men? It’s real sad to think about the concept that we may have polluted our own bodies, and that bioaccumulating effects could take males out of the equation entirely someday. Takeaway - Regulate the chemical industry. Invest in female biology. Invest in de-pollution research. Support LGBTQ 🏳️🌈 rights to accommodate for a gender inclusive world.
The potential impacts of micro-and-nano plastics on various organ systems in humans
thelancet.com
To view or add a comment, sign in
-
Did you hear that Dan Jing Wu, CEO & Co-Founder VivArt-X, is one of the 5️⃣0️⃣ Global Rising Stars in ESG of 2024? ⭐ Congratulations on this much-deserved recognition! "What a remarkable week! Received the amazing news of being selected as one of the 50 global Rising Stars in ESG 2024 by the Women of the Future Programme! It’s truly an honor, and to top it off, being mentioned in the Financial Times UK is a bucket-list moment," says Dan Jing Wu after the list announcement. ESG stands for Environmental, Social and Governance. In the words of the program, "ESG is a wide-ranging and fast-moving field. It provides a framework for assessing how a company is performing against its commitments to shape a better world." The annual list seeks to celebrate the talented female trailblazers and role models aged 35 and under from around the world who are at the forefront of ESG. In Dan Jing Wu's profile, she was asked about the defining moment that inspired her to pursue an ESG related career? Here's what she said: "It was my childhood dream to help and heal people when they became sick, inspired by witnessing a family member struggle with illness. After completing my PhD in biomedical engineering, I aimed to bring innovative techniques to patients. That is how VivArt-X came to life." VivArt-X develops personalized, regenerative materials for women's health. Its revolutionary synthetic, degradable biomaterial will revolutionize breast reconstructive surgery in women who have undergone breast tissue removal after breast cancer diagnosis, offering personalized breast reconstruction and regeneration. For more information on the list, click here > https://lnkd.in/etwPykR9 #borskifund #femalefounders #innovation #venturecapital #impactinvesting #startup
To view or add a comment, sign in
-
A few genuine scientists can excel in both, science and business.
"The reality about this program is, you don’t have to be lucky. The program makes you lucky." Meet the Innovative Genomics Institute's HS Chau Women in Enterprising Science Program (WIES). Now in its second cohort, this program guides women and provides support as they conduct research and found their own biotech startups. The above quote comes from current fellow Kelsey Hern, PhD, quoted by San Francisco Business Times' Ron Leuty in his profile of WIES and what it is accomplishing. Learn more about Kelsey and other WIES fellows at the below link. #ucberkeleyinnovation #womeninbusiness #womeninscience #biotech
Jennifer Doudna's Women In Enterprising Science incubator is giving young women scientists room to grow - San Francisco Business Times
bizjournals.com
To view or add a comment, sign in
685 followers